# Effect of Intravenous Iron on Quality of Life in Older Patients With Acute Coronary Syndrome

Study · id `cardio:ct-nct07476859` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07476859](<https://clinicaltrials.gov/study/NCT07476859>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT07476859

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease; Acute care and long-term living  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 538 participants.

## Technical summary

Registry record NCT07476859. Randomized; no masking; primary purpose treatment. Start 2026-03-05 (actual); primary completion 2028-04 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 538 participants (planned count; ClinicalTrials.gov record NCT07476859, source copy `cardio:ctgov-nct07476859-2026-03-24`, retrieved 2026-10-26)
- Started: 2026-03-05 (actual) (ClinicalTrials.gov record NCT07476859, source copy `cardio:ctgov-nct07476859-2026-03-24`, retrieved 2026-10-26)
- Primary completion: 2028-04 (anticipated) (ClinicalTrials.gov record NCT07476859, source copy `cardio:ctgov-nct07476859-2026-03-24`, retrieved 2026-10-26)
- Completion: 2028-05 (anticipated) (ClinicalTrials.gov record NCT07476859, source copy `cardio:ctgov-nct07476859-2026-03-24`, retrieved 2026-10-26)
- Countries: Spain (ClinicalTrials.gov record NCT07476859, source copy `cardio:ctgov-nct07476859-2026-03-24`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07476859-2026-03-24`, retrieved 2026-10-26)

## The registry's words

- Brief title: Effect of Intravenous Iron on Quality of Life in Older Patients With Acute Coronary Syndrome
- Acronym: HI-COR-65
- Condition: Acute Coronary Syndromes (ACS)
- Condition: Iron Deficiencies
- Condition: Elderly (People Aged 65 or More)
- Intervention (Drug): Ferric Carboxymaltose Injection \[Ferinject\]
- Lead sponsor: Fundación para la Investigación del Hospital Clínico de Valencia
- Lead sponsor class: OTHER
- Collaborator: AstraZeneca
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Acute coronary syndrome (`cardio:acute-coronary-syndrome`)
- Registry condition terms include this condition: Heart attack (myocardial infarction) (`cardio:myocardial-infarction`)
- Registry intervention name matches this record once doses, forms and salt words are removed: Ferric carboxymaltose (`core:ferric-carboxymaltose`)
- Registry lists this organization as the lead sponsor: Fundación para la Investigación del Hospital Clínico de Valencia (`cardio:org-fundacion-para-la-investigacion-del-hospital-clinico-de-7ad3f9`)
- Registry lists this organization as a collaborator: AstraZeneca (`cardio:astrazeneca`)

## Provenance

Content hash: fe829d6dd7209b2acc7a89d264f3f65122905b222fb2f5ee8b9f1185ebe65374
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
